CN118613464A - 丙戊酸的新型类似物以及使用其的药物治疗方法 - Google Patents
丙戊酸的新型类似物以及使用其的药物治疗方法 Download PDFInfo
- Publication number
- CN118613464A CN118613464A CN202280084449.3A CN202280084449A CN118613464A CN 118613464 A CN118613464 A CN 118613464A CN 202280084449 A CN202280084449 A CN 202280084449A CN 118613464 A CN118613464 A CN 118613464A
- Authority
- CN
- China
- Prior art keywords
- fibrosis
- compound
- subject
- pharmaceutical composition
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/126—Acids containing more than four carbon atoms
- C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/001—Acyclic or carbocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2118559.0 | 2021-12-20 | ||
| GB2118559.0A GB2613900B (en) | 2021-12-20 | 2021-12-20 | Novel compounds and methods of use thereof |
| PCT/GB2022/053318 WO2023118846A1 (en) | 2021-12-20 | 2022-12-20 | Novel analogs of valproic acid and methods of medical treatment using the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN118613464A true CN118613464A (zh) | 2024-09-06 |
Family
ID=84887257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280084449.3A Pending CN118613464A (zh) | 2021-12-20 | 2022-12-20 | 丙戊酸的新型类似物以及使用其的药物治疗方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250066282A1 (https=) |
| EP (1) | EP4452917A1 (https=) |
| JP (1) | JP2025500459A (https=) |
| KR (1) | KR20240152301A (https=) |
| CN (1) | CN118613464A (https=) |
| AU (1) | AU2022422574A1 (https=) |
| CA (1) | CA3242987A1 (https=) |
| GB (1) | GB2613900B (https=) |
| IL (1) | IL313669A (https=) |
| MX (1) | MX2024007654A (https=) |
| WO (1) | WO2023118846A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2644641A (en) * | 2024-09-24 | 2026-04-29 | Cereno Scient Ab | New methods |
| WO2026068561A1 (en) | 2024-09-24 | 2026-04-02 | Cereno Scientific Ab | Valproic acid for use in treating pulmonary arterial hypertension |
| GB2644610A (en) * | 2024-09-27 | 2026-04-22 | Cereno Scient Ab | New methods |
| WO2026068552A1 (en) | 2024-09-24 | 2026-04-02 | Cereno Scientific Ab | Deuterated valproic acid compounds for use in treating pulmonary arterial hypertension |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120071554A1 (en) * | 2008-10-28 | 2012-03-22 | Liu Julie F | Deuterated 2-propylpentanoic acid compounds |
| US20100143507A1 (en) * | 2008-12-09 | 2010-06-10 | Auspex Pharmaceuticals, Inc. | Carboxylic acid inhibitors of histone deacetylase, gaba transaminase and sodium channel |
| GB201417828D0 (en) * | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
| RU2760304C2 (ru) * | 2016-04-08 | 2021-11-23 | Серено Сайентифик Аб | Фармацевтические составы с отсроченным высвобождением, содержащие вальпроевую кислоту, и их применение |
-
2021
- 2021-12-20 GB GB2118559.0A patent/GB2613900B/en active Active
-
2022
- 2022-12-20 MX MX2024007654A patent/MX2024007654A/es unknown
- 2022-12-20 CA CA3242987A patent/CA3242987A1/en active Pending
- 2022-12-20 JP JP2024538134A patent/JP2025500459A/ja active Pending
- 2022-12-20 AU AU2022422574A patent/AU2022422574A1/en active Pending
- 2022-12-20 IL IL313669A patent/IL313669A/en unknown
- 2022-12-20 WO PCT/GB2022/053318 patent/WO2023118846A1/en not_active Ceased
- 2022-12-20 EP EP22839416.9A patent/EP4452917A1/en active Pending
- 2022-12-20 CN CN202280084449.3A patent/CN118613464A/zh active Pending
- 2022-12-20 US US18/721,594 patent/US20250066282A1/en active Pending
- 2022-12-20 KR KR1020247024372A patent/KR20240152301A/ko active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| GB2613900A (en) | 2023-06-21 |
| IL313669A (en) | 2024-08-01 |
| KR20240152301A (ko) | 2024-10-21 |
| CA3242987A1 (en) | 2023-06-29 |
| MX2024007654A (es) | 2024-07-04 |
| GB2613900B (en) | 2024-01-17 |
| AU2022422574A1 (en) | 2024-07-18 |
| EP4452917A1 (en) | 2024-10-30 |
| US20250066282A1 (en) | 2025-02-27 |
| WO2023118846A1 (en) | 2023-06-29 |
| JP2025500459A (ja) | 2025-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN118613464A (zh) | 丙戊酸的新型类似物以及使用其的药物治疗方法 | |
| ES3058168T3 (en) | Resorcinol derivative as a pharmaceutically active compound and method of preparation thereof | |
| ES2892954T3 (es) | Derivados fluorados del ácido 3-(2-oxo-3-(3-(5,6,7,8-tetrahidro-1,8-naftiridin-2-il)propil)imidazolidin-1-il)propanoico y usos de los mismos | |
| JP4775259B2 (ja) | アニリン誘導体 | |
| IL305157A (en) | Terpanstinil derivatives and preparations containing them and their uses | |
| TW201028380A (en) | C5aR antagonists | |
| JP6114316B2 (ja) | カルシウム感知受容体調節剤としての置換クロマン化合物 | |
| TWI774683B (zh) | sGC刺激劑之固體形式 | |
| JP2010143937A (ja) | 抗凝血薬として用いるクマリン誘導体 | |
| JP2025164962A (ja) | ミトコンドリア病の治療のためのキノン類似体、ヒドロキノン類似体及びナフトキノン類似体 | |
| AU2021273632A1 (en) | N-acylethanolamide derivatives and uses thereof | |
| CN105777464A (zh) | 异羟肟酸衍生物及其制备方法和应用 | |
| WO2016027241A1 (en) | Novel iminonitrile derivatives | |
| WO2025139406A1 (zh) | 二苯基吡嗪类化合物及其组合物、应用和制备方法 | |
| BR112019000290B1 (pt) | Prófármacos de fósforo dos estimuladores da sgc | |
| KR101061764B1 (ko) | 신경보호효과를 가지는 피루베이트 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
| AU2024309112A1 (en) | Substituted cyclic compounds and methods of treating phenylketonuria and other amino acidurias | |
| JPS602295B2 (ja) | 2−プロピル吉草酸ピバロイルオキシメチル、その製法および抗てんかん剤または鎮痙剤 | |
| WO2012139422A1 (zh) | 新型抗血小板化合物的加成盐 | |
| CN115557898B (zh) | 一种咪唑类化合物、其中间体及应用 | |
| TW201700474A (zh) | 新的5型磷酸二酯酶抑制劑及其醫藥應用 | |
| JP2025533120A (ja) | イミダゾリジニルバニリン酸エーテル誘導体の線維化を伴う疾患の治療における使用 | |
| WO2026068552A1 (en) | Deuterated valproic acid compounds for use in treating pulmonary arterial hypertension | |
| JPH11503129A (ja) | 新規の複素環化合物 | |
| KR20240111305A (ko) | 페롭토시스 유도 활성을 갖는 화합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |